These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3056429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

  • 3. Long-term effect of lovastatin alone and in combination with cholestyramine on lipoprotein (a) level in familial hypercholesterolemic subjects.
    Leren TP, Hjermann I, Foss OP, Leren P, Berg K.
    Clin Investig; 1992 Aug; 70(8):711-8. PubMed ID: 1392453
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
    Uusitupa M, Ebeling T, Happonen P, Voutilainen E, Turtola H, Parviainen M, Pyörälä K.
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):496-503. PubMed ID: 1724525
    [Abstract] [Full Text] [Related]

  • 5. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H, Sakai T, Sakai Y, Yoshimura A, Watanabe A, Wakasugi T, Koizumi J, Takeda R.
    N Engl J Med; 1983 Mar 17; 308(11):609-13. PubMed ID: 6828091
    [Abstract] [Full Text] [Related]

  • 6. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM, Parra HJ, Douste-Blazy P, Fruchart JC.
    Metabolism; 1990 Mar 17; 39(3):269-73. PubMed ID: 2106607
    [Abstract] [Full Text] [Related]

  • 7. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
    Stugaard M, Wiig I, Lund H, Ose L, Norseth J.
    Tidsskr Nor Laegeforen; 1992 Aug 30; 112(20):2642-6. PubMed ID: 1412289
    [Abstract] [Full Text] [Related]

  • 8. Combination drug therapy with HMG CoA reductase inhibitors and bile acid sequestrants for hypercholesterolemia.
    Erkelens DW.
    Cardiology; 1990 Aug 30; 77 Suppl 4():33-8. PubMed ID: 2073670
    [Abstract] [Full Text] [Related]

  • 9. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 30; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW, Baggen MG, Van Doormaal JJ, Kettner M, Koningsberger JC, Mol MJ.
    Drugs; 1988 Feb 30; 36 Suppl 3():87-92. PubMed ID: 3254824
    [Abstract] [Full Text] [Related]

  • 11. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul 15; 260(3):359-66. PubMed ID: 2898027
    [Abstract] [Full Text] [Related]

  • 12. Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
    Ebeling T, Turtola H, Voutilainen E, Uusitupa M, Pyörälä K, Reijonen T.
    Ann Med; 1992 Apr 15; 24(2):121-7. PubMed ID: 1610539
    [Abstract] [Full Text] [Related]

  • 13. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Apr 15; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 14. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
    Jacob BG, Richter WO, Schwandt P.
    J Cardiovasc Pharmacol; 1993 Sep 15; 22(3):396-400. PubMed ID: 7504129
    [Abstract] [Full Text] [Related]

  • 15. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 16. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP, Illingworth DR.
    Metabolism; 1990 Feb 10; 39(2):150-4. PubMed ID: 2299987
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
    Mabuchi H, Koizumi J, Kajinami K.
    Am J Cardiol; 1998 Aug 27; 82(4B):52J-55J. PubMed ID: 9737647
    [Abstract] [Full Text] [Related]

  • 18. Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Jacob BG, Möhrle W, Richter WO, Schwandt P.
    Eur J Clin Pharmacol; 1992 Aug 27; 42(4):353-8. PubMed ID: 1516599
    [Abstract] [Full Text] [Related]

  • 19. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
    Wiklund O, Angelin B, Fager G, Eriksson M, Olofsson SO, Berglund L, Lindén T, Sjöberg A, Bondjers G.
    J Intern Med; 1990 Sep 27; 228(3):241-7. PubMed ID: 2119417
    [Abstract] [Full Text] [Related]

  • 20. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May 27; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.